Insider · CIK 0001880946

Bensen Daniel

Reports to the SEC for 1 company · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001880946

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−2,128 sh	$31.50	−$67K	152,853
2026-02-12	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−5,872 sh	$33.37	−$196K	146,981
2026-01-12	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−6,983 sh	$28.44	−$199K	155,998
2026-01-12	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−1,017 sh	$29.08	−$29.6K	154,981
2025-12-12	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−8,000 sh	$22.64	−$181K	162,981
2025-11-19	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−50K sh	$16.32	−$815K	170,981
2025-11-18	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−75.6K sh	$16.07	−$1.22M	220,937
2025-11-17	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−18.6K sh	$16.11	−$299K	298,070
2025-11-17	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−1,500 sh	$17.07	−$25.6K	296,570
2025-11-14	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−110K sh	$16.02	−$1.77M	316,642
2025-11-13	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−1,111 sh	$16.00	−$17.8K	426,870
2025-08-07	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+170K sh	—	—	170,000
2024-08-14	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+115K sh	—	—	115,000
2024-06-10	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−3,502 sh	$20.00	−$70K	427,981
2024-06-07	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−200 sh	$20.00	−$4,000	431,483
2024-03-11	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−200 sh	$20.00	−$4,000	431,683
2024-03-07	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−68 sh	$20.00	−$1,360	431,883
2024-03-06	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−1,733 sh	$20.09	−$34.8K	431,951
2024-03-05	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−1,189 sh	$20.02	−$23.8K	433,684
2024-03-04	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−5,063 sh	$20.08	−$102K	434,873
2024-03-01	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−2,900 sh	$20.04	−$58.1K	439,936
2024-02-29	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−2,050 sh	$20.00	−$41K	442,836
2024-02-28	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−5,849 sh	$20.13	−$118K	444,886
2024-02-27	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−745 sh	$20.00	−$14.9K	450,735
2024-02-12	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−1,501 sh	$20.00	−$30K	451,480
2024-02-07	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−9,587 sh	$18.09	−$173K	452,981
2024-02-06	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−15.4K sh	$18.09	−$279K	462,568
2024-02-02	TYRATyra Biosciences, Inc.M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+25.4K sh	$0.61	+$15.5K	553,374
2024-02-02	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−73.1K sh	$16.31	−$1.19M	480,281
2024-02-02	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−2,300 sh	$17.04	−$39.2K	477,981
2024-02-02	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−25.4K sh	—	—	108,110
2023-07-28	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Discovery Officer	AAward	+110K sh	—	—	110,000
2023-07-21	TYRATyra Biosciences, Inc.M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+3,900 sh	$0.61	+$2,379	531,881
2023-07-21	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−3,900 sh	$16.01	−$62.4K	527,981
2023-07-21	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−3,900 sh	—	—	133,503
2023-07-19	TYRATyra Biosciences, Inc.M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+207 sh	$0.61	+$126.27	528,188
2023-07-19	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−207 sh	$16.07	−$3,327.525	527,981
2023-07-19	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−207 sh	—	—	137,403
2023-07-17	TYRATyra Biosciences, Inc.M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+1,900 sh	$0.61	+$1,159	529,881
2023-07-17	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−1,900 sh	$16.03	−$30.5K	527,981
2023-07-17	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−1,900 sh	—	—	137,610
2023-07-13	TYRATyra Biosciences, Inc.M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+500 sh	$0.61	+$305	528,481
2023-07-13	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−500 sh	$16.13	−$8,065	527,981
2023-07-13	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−500 sh	—	—	139,510
2023-07-12	TYRATyra Biosciences, Inc.M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+201 sh	$0.61	+$122.61	528,182
2023-07-12	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−201 sh	$16.23	−$3,262.31	527,981
2023-07-11	TYRATyra Biosciences, Inc.M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	+500 sh	$0.61	+$305	528,481
2023-07-11	TYRATyra Biosciences, Inc.S Sale	Chief Discovery Officer	SSale	−500 sh	$16.02	−$8,009.5	527,981
2023-07-11	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−500 sh	—	—	140,211
2023-07-11	TYRATyra Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Discovery Officer	MExercise/Conversion	−201 sh	—	—	140,010

Recent filings

Accepted (ET)
Feb 134
Bensen Daniel0001193125-26-051534
SEC(opens sec.gov)
Jan 204
Bensen Daniel0001193125-26-016651
SEC(opens sec.gov)
Dec 164
Bensen Daniel0001193125-25-320941
SEC(opens sec.gov)
Nov 194
Bensen Daniel0001193125-25-288529
SEC(opens sec.gov)
Nov 174
Bensen Daniel0001193125-25-284935
SEC(opens sec.gov)
Aug 74
Bensen Daniel0000950170-25-105140
SEC(opens sec.gov)
Aug 164
Bensen Daniel0000950170-24-098179
SEC(opens sec.gov)
Jun 104
Bensen Daniel0000950170-24-071500
SEC(opens sec.gov)
Mar 134
Bensen Daniel0000950170-24-030932
SEC(opens sec.gov)
Mar 84
Bensen Daniel0000950170-24-028807
SEC(opens sec.gov)
Mar 54
Bensen Daniel0000950170-24-026365
SEC(opens sec.gov)

Companies

Tyra Biosciences, Inc.Chief Discovery OfficerTYRA

Address

C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET

CARLSBAD, CA, 92008